Meteospasmil (simeticone) capsules №30

Description

Meteospasmil composition
active substances:
1 capsule contains alverine citrate 60 mg; simethicone 300 mg;
Excipients: gelatin, glycerin, titanium dioxide (E 171).

Dosage form
Capsules.

Pharmacological properties
This drug Meteospasmil belongs to the group of combined carminative drugs used to treat diseases of the gastrointestinal tract, characterized by increased gas production (flatulence).
Simethicone is an organosilicon ingredient included in the group of polydimethylsiloxane compounds. Has the properties of a surfactant. It is a drug capable of inhibiting (inhibiting) the phenomenon of flatulence in the area of ​​the gastrointestinal tract.
It is able to reduce the so-called “surface tension”, which is formed at the boundary of the phase of formation of gas from liquids, complicating the likelihood of the appearance of gases, causes the destruction of already formed gas bubbles. It is active both in the food liquid and in the mucus in the digestive tract.
Thus, simethicone exhibits an “antifoam” effect and is used to treat bloating and stomach cramps.
Also, the composition of the drug includes alverine citrate, which has an atropine-like effect and helps to reduce the intensity and number of spasms in the gastrointestinal tract.

Indications
This medicinal product Meteospasmil is used to treat all types of excessive gas formation, flatulence. Including when:

• aerophagia;
• flatulence in the postoperative period;
• flatulence in newborns.

It is also used as an aid in carrying out diagnostic measures for examining the abdominal cavity – conducting an X-ray, ultrasound, gastrofibroscopy.
It is also used for poisoning with surfactants (detergents).

Contraindications
The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.
Also, use is contraindicated in:

• intestinal obstruction;
• obstructive diseases of the gastrointestinal tract.

Application during pregnancy and lactation
This drug is not recommended for use in pregnant women.
If it is necessary to take the drug during breastfeeding, then lactation should be suspended during treatment.

Method of administration and dosage
Meteospasmil is taken orally, by mouth, before each meal or during it, 2-3 times a day (possible at night) with a small amount of liquid.
It is permissible to take up to 4 times per day.
The duration of treatment is individual, depending on the course of the disease.
Patients should follow the diet prescribed by the doctor, since the drug does not eliminate the causes of the disease and only eliminates its symptom in the form of flatulence.
In preparation for diagnostic tests, take 1 tablet 2 times a day (within 2 days before the study) and 1 tablet – in the morning on the day of the procedure.

Overdose
Overdose has not been recorded at the moment, since the drug does not enter the body and is completely removed from it unchanged.

Side effects
The use of this drug usually does not cause side effects, since the drug does not enter the body and is completely removed from it unchanged.
In the event of reactions of individual intolerance, allergic reactions may appear in the form of:

• allergic urticaria;
• rashes;
• itchy skin;
• hyperemia;
• other types of allergic reactions.

Storage conditions and periods
The shelf life is up to 3 years.
Storage temperature should not exceed 25 ° C.